KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Equity Average (2021 - 2025)

Historic Equity Average for Organon (OGN) over the last 5 years, with Q3 2025 value amounting to $819.5 million.

  • Organon's Equity Average rose 15729.98% to $819.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $819.5 million, marking a year-over-year increase of 15729.98%. This contributed to the annual value of $201.0 million for FY2024, which is 14178.79% up from last year.
  • According to the latest figures from Q3 2025, Organon's Equity Average is $819.5 million, which was up 15729.98% from $637.5 million recorded in Q2 2025.
  • Over the past 5 years, Organon's Equity Average peaked at $5.1 billion during Q1 2021, and registered a low of -$1.8 billion during Q3 2021.
  • Moreover, its 5-year median value for Equity Average was -$329.5 million (2023), whereas its average is -$52.9 million.
  • Its Equity Average has fluctuated over the past 5 years, first tumbled by 18561.69% in 2022, then surged by 470909.09% in 2025.
  • Quarter analysis of 5 years shows Organon's Equity Average stood at -$1.6 billion in 2021, then skyrocketed by 37.36% to -$979.0 million in 2022, then soared by 66.34% to -$329.5 million in 2023, then soared by 246.43% to $482.5 million in 2024, then skyrocketed by 69.84% to $819.5 million in 2025.
  • Its Equity Average stands at $819.5 million for Q3 2025, versus $637.5 million for Q2 2025 and $507.0 million for Q1 2025.